|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
UA129778C2
(uk)
|
2019-10-28 |
2025-07-30 |
Мерк Шарп Енд Доум Елелсі |
Низькомолекулярні інгібітори g12c-мутантного kras
|
|
EP4067343A4
(en)
|
2019-11-29 |
2024-01-03 |
Taiho Pharmaceutical Co., Ltd. |
NEW PHENOLIC COMPOUND OR SALT THEREOF
|
|
CA3191279A1
(en)
|
2020-08-28 |
2022-03-03 |
Yi Liu |
Heterocyclic compounds and uses thereof
|
|
MX2023010430A
(es)
*
|
2021-03-12 |
2023-09-12 |
Bristol Myers Squibb Co |
Inhibidores del homologo del oncogen viral del sarcoma de rata kirsten con mutacion g12d (kras g12d).
|
|
MX2023012725A
(es)
*
|
2021-04-29 |
2024-09-23 |
Amgen Inc |
Compuestos de 2-aminobenzotiazol y metodos de uso de los mismos.
|
|
US20250059205A1
(en)
*
|
2021-04-29 |
2025-02-20 |
Amgen Inc. |
Heterocyclic Compounds and Methods of Use
|
|
WO2022261154A1
(en)
*
|
2021-06-09 |
2022-12-15 |
Eli Lilly And Company |
Substituted fused azines as kras g12d inhibitors
|
|
IL310291A
(en)
*
|
2021-07-23 |
2024-03-01 |
Theras Inc |
Compositions and methods for inhibition of ras
|
|
US20240409558A1
(en)
*
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
WO2023061294A1
(zh)
*
|
2021-10-13 |
2023-04-20 |
再鼎医药(上海)有限公司 |
含氮杂环类衍生物调节剂、其制备方法及应用
|
|
WO2023072188A1
(zh)
*
|
2021-10-29 |
2023-05-04 |
贝达药业股份有限公司 |
Kras g12d抑制剂及其在医药上的应用
|
|
CN116253748A
(zh)
*
|
2021-12-09 |
2023-06-13 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
WO2023114733A1
(en)
*
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
AR128212A1
(es)
*
|
2022-01-06 |
2024-04-10 |
Theras Inc |
Composiciones y métodos para la inhibición de ras
|
|
AR128211A1
(es)
*
|
2022-01-06 |
2024-04-10 |
Theras Inc |
Composiciones y métodos para la inhibición de ras
|
|
CN118556063A
(zh)
*
|
2022-01-21 |
2024-08-27 |
上海湃隆生物科技有限公司 |
杂环类化合物、药物组合物及其应用
|
|
EP4371991A4
(en)
|
2022-01-21 |
2025-02-26 |
Usynova Pharmaceuticals Ltd. |
Benzopyrimidine compounds and use thereof
|
|
AU2023216698A1
(en)
*
|
2022-02-03 |
2024-06-13 |
Mirati Therapeutics, Inc. |
Quinazoline pan-kras inhibitors
|
|
CA3243798A1
(en)
|
2022-02-09 |
2023-08-17 |
Quanta Therapeutics, Inc. |
Kras Modulators and Their Uses
|
|
MX2024010045A
(es)
*
|
2022-02-16 |
2024-08-26 |
Amgen Inc |
Compuestos de quinazolina y uso de los mismos como inhibidores de proteinas mutantes kras.
|
|
EP4479398A1
(en)
*
|
2022-02-16 |
2024-12-25 |
Amgen Inc. |
Quinazoline compounds and use thereof as inhibtors of mutant kras proteins
|
|
AU2023231139A1
(en)
|
2022-03-11 |
2024-09-05 |
Kumquat Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
JP2025510656A
(ja)
*
|
2022-03-24 |
2025-04-15 |
ベイジーン スウィッツァーランド ゲーエムベーハー |
複素環式化合物、その組成物、及びそれらを用いた治療方法
|
|
CN116891488B
(zh)
*
|
2022-04-11 |
2025-12-12 |
成都海博为药业有限公司 |
稠环化合物、包含其的药物组合物及应用
|
|
WO2023225252A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
WO2023230190A1
(en)
|
2022-05-25 |
2023-11-30 |
Quanta Therapeutics, Inc. |
Pyrimidine based modulators and uses thereof
|
|
WO2023246777A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Jacobio Pharmaceuticals Co., Ltd. |
K-ras mutant protein inhibitors
|
|
WO2024008179A1
(en)
*
|
2022-07-07 |
2024-01-11 |
Beigene, Ltd. |
Heterocyclic compounds, compositions thereof, and methods of treatment therewith
|
|
IL318647A
(en)
|
2022-08-05 |
2025-03-01 |
Kumquat Biosciences Inc |
Heterocyclic compounds and their uses
|
|
US20260035376A1
(en)
|
2022-08-05 |
2026-02-05 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
US20260042764A1
(en)
*
|
2022-08-05 |
2026-02-12 |
Theras, Inc. |
Compositions and methods for inhibition of kras
|
|
US20260083750A1
(en)
*
|
2022-08-26 |
2026-03-26 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|
|
WO2024063576A1
(ko)
*
|
2022-09-23 |
2024-03-28 |
일동제약(주) |
Kras 저해 물질로서 신규한 퀴나졸린 화합물
|
|
CN120077051A
(zh)
*
|
2022-10-21 |
2025-05-30 |
苏州亚盛药业有限公司 |
Kras抑制剂
|
|
AU2023382606A1
(en)
*
|
2022-11-14 |
2025-05-08 |
Amgen Inc. |
Macrocyclic kras inhibitors and methods of use
|
|
CN116554208A
(zh)
*
|
2022-12-02 |
2023-08-08 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
CN116082115A
(zh)
*
|
2023-01-06 |
2023-05-09 |
河南省科学院化学研究所有限公司 |
一种2-溴-4-氯-9,9’-二甲基芴的合成方法
|
|
KR20260041941A
(ko)
|
2023-03-15 |
2026-03-27 |
콴타 테라퓨틱스, 인크. |
Kras 조절 인자 및 이의 용도
|
|
KR20250164300A
(ko)
*
|
2023-03-30 |
2025-11-24 |
일라이 릴리 앤드 캄파니 |
KRas 억제제
|
|
WO2024243025A1
(en)
*
|
2023-05-19 |
2024-11-28 |
Ikena Oncology, Inc. |
Naphthyl-substituted pyrido[4,3-d]pyrimidines and related compounds and their use in treating medical conditions
|
|
CN121464141A
(zh)
*
|
2023-06-29 |
2026-02-03 |
海思科医药集团股份有限公司 |
一种5元杂芳基衍生物及其在医药上的应用
|
|
WO2025019823A1
(en)
*
|
2023-07-20 |
2025-01-23 |
Merck Sharp & Dohme Llc |
Small molecule protein degraders of kras g12d mutant
|
|
WO2025049402A1
(en)
*
|
2023-08-28 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
AU2024337016A1
(en)
*
|
2023-09-08 |
2026-04-16 |
Tyligand Bioscience (Shanghai) Limited |
Ras inhibitor
|
|
CN121969634A
(zh)
*
|
2023-10-08 |
2026-05-01 |
成都海博为药业有限公司 |
一种稠环化合物及应用
|
|
US20250114346A1
(en)
|
2023-10-09 |
2025-04-10 |
Incyte Corporation |
Combination therapy using a kras g12d inhibitor and pd-1 inhibitor or pd-l1 inhibitor
|
|
US20250114339A1
(en)
|
2023-10-09 |
2025-04-10 |
Incyte Corporation |
Combination therapy comprising a kras g12d inhibitor and an egfr inhibitor
|
|
AU2024361909A1
(en)
|
2023-10-20 |
2026-03-26 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|
|
WO2025090811A1
(en)
*
|
2023-10-25 |
2025-05-01 |
Kumquat Biosciences Inc. |
Methods of modulating cell proliferation
|
|
WO2025117828A1
(en)
*
|
2023-12-01 |
2025-06-05 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|